Figure 2From: Effectiveness of interferon-beta and temozolomide combination therapy against temozolomide-refractory recurrent anaplastic astrocytomaPhotomicrograph. H&E staining (A) and immunohistochemical staining for MGMT protein (B) of the tumor resected at initial surgery. Forty-eight percent (± 3.7%) of the tumor cells express MGMT protein.Back to article page